IMPAIRED PROLIFERATION AND DIFFERENTIATION OF MYELODYSPLASTIC CD34+ CELLS

被引：12
作者：
SAWADA, K
机构：
[1] Department of Internal Medicine II, Hokkaido University School of Medicine, Sapporo
来源：
LEUKEMIA & LYMPHOMA | 1994年 / 14卷 / 1-2期
关键词：
MDS; CD34; PURIFICATION; SERUM-FREE MEDIUM; G-CSF;
D O I：
10.3109/10428199409049649
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The myelodysplastic syndromes (MDS) are a heterogeneous group of disorders of hematopoiesis entailing hyperproliferative and ineffective hematopoiesis resulting in refractory cytopenia(s), and increased risk of transformation into acute myeloblastic leukemia (AML). The widely used classification defined by the French-American-British group (FAB) recognizes 5 cytological subtypes of different prognosis, based essentially on the presence and the frequency of marrow blasts. The percentage of marrow blasts does not exceed 30%, hence, direct investigations of biological and biochemical events of MDS blast cells have been hampered. The CD34 antigen is currently unique in its narrow specificity of expression on human lymphohematopoietic progenitor cells. This cell membrane phosphoglycoprotein has been used for immunologic blast cell purification, notwithstanding the frequency of marrow blasts, and has provided a set of tools for investigations of MDS i.e. a direct comparison of the nature of blast cells in each of the MDS subtypes, using immunologic, biologic, biochemical and molecular biological methodology. A combination of serum-free medium and a purification method for blast cells provided evidence that the progenitor eel growth abnormalities in these disorders involve a defect in the capacity of progenitor cells to respond to stimulation with growth factor(s), and has presented direct evidence for the manner in which myelodysplastic CD34(+) cells are impaired.
引用
收藏
页码：37 / 47
页数：11
相关论文
共 116 条
[21]  
Leary A.G., Ogawa M., Strauss L.C., Civin C.I., Single cell origin of multilineage colonies in culture: evidence that differentiation of multipotent progenitors and restriction of proliferative potential of monopotent progenitors are stochastic process, J. Clin. Invest., 74, pp. 2193-2197, (1984)
[22]  
Schmitt C., Eaves C.J., Lansdorp P.M., Expression of CD34 on human B cell precursors, Clin. Exp. Immunol., 85, pp. 168-173, (1991)
[23]  
Tindle R.W., Nichols R.A.B., Chan L.C., Campana D., Birnie G., A novel monoclonal antibody BI.3C5 recognizes myeloblasts and non B., non T lymphoblasts in acute leukemias and CGL blast crisis and reacts with immature cells in normal bone marrow, Leukemia Res., 9, pp. 1-9, (1984)
[24]  
Civin C.I., Human monomyeloid cell membrane antigens, Exp. Hematol., 18, pp. 461-467, (1990)
[25]  
Terstappen L.W.M.M., Huang S., Safford M., Lansdorp P.M., Loken M.R., Sequential generations of hematopoietic colonies derived from single nonlineagecommitted CD34+CD38− progenitor cells, Blood, 77, pp. 1218-1227, (1991)
[26]  
Verfaillie C., Blakolmer K., McGlave P., Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma, J. Exp. Med., 172, pp. 509-520, (1990)
[27]  
Brandt J., Srour E.F., van Besien K., Briddell R.A., Hoffman R., Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow, J. Clin. Invest., 86, pp. 932-941, (1990)
[28]  
Bender J.G., Unverzagt K.L., Walker D.E., Lee W., van Epps D.E., Smith D.H., Stewart C.C., To L.B., Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry, Blood, 77, pp. 2591-2596, (1991)
[29]  
Egeland T., Steen R., Quarsten H., Gaudernack G., Yang Y.-C., Thorsby E., Myeloid differentiation of purified CD34 cells after stimulation with recombinant human granulocyte-monocyte colony-stimulating factor (CSF), granulocyte-CSF, monocyte-CSF, and interleukin-3, Blood, 78, pp. 3192-3199, (1991)
[30]  
Lu L., Walker D., Broxmeyer H.E., Hoffman R., Hu W., Walker E., Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My 10 and major histocompatibility class II monoclonal antibodies, J. Immunol., 139, pp. 1823-1829, (1987)
12345678910